Clinical Services
Regulatory expertise
that opens doors.
From DTAC submission to embedded CSO coverage, our services are designed to take digital health companies from regulatory uncertainty to UK and global procurement readiness without the complexity of building in-house capability.
sdha-logo-header

Our Markets

Four markets. One standard.
We do not adapt our standards to each market — we bring UK-grade clinical governance to each context, adapted to the local regulatory framework, creating a truly global standard of care.

🇳🇬 Nigeria

Nigeria's Federal Ministry of Health is actively building a digital health regulatory framework, including the National Digital Health Policy and the NDPA (Nigeria Data Protection Act). SDHA is advising on UK-standard clinical safety for Nigerian health tech organisations and international companies entering the Nigerian market.
  • Clinical safety framework design aligned to NDPA and FMoH policy
  • Digital health product safety assessment
  • UK-to-Nigeria regulatory translation advisory
  • Health data governance and NDPA compliance
  • Telemedicine and e-health platform advisory

🇮🇳 India

India's digital health market is growing at 39% annually, driven by the Ayushman Bharat Digital Mission (ABDM) and a rapidly expanding private health tech sector. SDHA advises Indian health tech companies on international market entry — particularly UK and GCC regulatory requirements — and Indian health organisations on UK-standard clinical governance.
  • ABDM-aligned clinical safety advisory
  • UK market entry regulatory pathway for Indian health tech
  • CDSCO (India) medical device regulatory advisory
  • International investor-readiness clinical governance
  • Telemedicine and AI diagnostic platform advisory

🇦🇪 Gulf Cooperation Council

With $20Bn+ in planned digital health investment across Saudi Arabia, UAE, Qatar, and Kuwait, the GCC is the fastest-growing digital health market outside East Asia. SDHA advises GCC health organisations and international companies entering the GCC on clinical safety standards aligned to SFDA, MOH UAE, and CDER frameworks.
  • SFDA (Saudi FDA) clinical safety advisory
  • UAE Ministry of Health regulatory alignment
  • AI health product governance for GCC deployment
  • Clinical safety case development for GCC procurement
  • UK-GCC health system comparison and gap analysis

🌏 Southeast Asia & Beyond

Singapore, Malaysia, Thailand, and Indonesia are developing sophisticated digital health regulatory frameworks.
SDHA provides advisory to organisations navigating multi-jurisdictional deployment helping health tech companies achieve clinical safety standards acceptable across multiple regulatory environments simultaneously.
  • HSA Singapore SaMD regulatory advisory
  • Multi-jurisdictional clinical safety framework design
  • WHO digital health standards alignment
  • Cross-border health data governance
  • International investor due diligence clinical safety review

First-Mover Position

No direct competitor on the ground

SDHA is the only organisation combining GMC-registered clinical authority with UK-standard regulatory expertise and active presence across all four international markets. There is no equivalent service in Nigeria, the GCC, India, or Southeast Asia, which is precisely the global opportunity.

Our international advisory is not a separate product; it is the same clinical rigour we apply to our UK and global work, translated into each regulatory context with the respect and precision that each market deserves.

International Enquiries

Need Consultation
Write me

General Enquires
Write us

Phone / WhatsApp
(+44) 07376 309 553

Book Discovery Call
SDHA Logo
About Us

The infrastructure layer that makes UK and global digital health work. Clinical authority meets digital innovation.

PRODUCTS
SERVICES
QUICK LINKS
Connect With Us

Email: Mail Us